61 studies found for:    NIAID | Recruiting | Exclude Unknown | allergy OR asthma OR diabetes OR transplant OR multiple sclerosis OR psoriatic arthritis OR lupus
Show Display Options
Rank Status Study
21 Recruiting Impact of Vaccination on Th2 Immunity in Infancy
Condition: Food Hypersensitivity
Interventions: Procedure: Skin prick allergen test;   Procedure: Blood draw
22 Recruiting Fel d 1 Peptide Immunotherapy Clinical Trial
Conditions: Cat Allergy;   Cat Hypersensitivity
Interventions: Drug: Cat-PAD;   Drug: Placebo
23 Recruiting Subcutaneous Immunotherapy for Mouse in Adults
Conditions: Asthma;   Perennial Allergic Rhinitis,
Intervention: Biological: Mouse Allergenic Extract
24 Recruiting BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
Condition: Kidney Transplantation
Interventions: Biological: Antithymocyte globulin (ATG);   Drug: Fludarabine;   Drug: Low dose Pre-transplant cyclophosphamide;   Radiation: Total Body Irradiation;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Methylprednisolone;   Biological: Bone Marrow;   Drug: MESNA;   Drug: Mycophenolate mofetil (MMF);   Drug: Prednisone;   Drug: Filgrastim;   Drug: High dose post-transplant cyclophosphamide
25 Recruiting T Cell Effector and Regulatory Mechanisms in Asthma
Conditions: Asthma;   Allergies
Interventions: Biological: Bronchoscopy, Segmental Allergen Challenge and Broncheoalveolar Lavage;   Procedure: PET-CT imaging(13NN perfusion/ventilation, 18FDG inflammation, and CT imaging)
26 Recruiting Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
Conditions: Asthma;   Allergies
Interventions: Biological: Bronchoscopy, Segmental Allergen Challenge and Bronchoalveolar Lavage;   Procedure: Phlebotomy
27 Recruiting B Cell Induction in Pediatric Lung Transplantation
Condition: Lung Transplant
Interventions: Biological: Rituximab (Rituxan®);   Biological: Placebo
28 Recruiting Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)
Condition: Hypersensitivity, Immediate
Interventions: Procedure: Nasal Allergen Challenge;   Other: Environmental Exposure Chamber;   Biological: Cat allergen (FelD1)
29 Recruiting Impact of Allo- and Autoantibodies on Chronic Cardiac Allograft Function
Conditions: Pediatric Heart Transplantation;   Pediatric Heart Transplant Recipients
Intervention:
30 Recruiting Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Allergic Asthma
Condition: Allergic Asthma
Interventions: Device: CREON2000A;   Device: Sham
31 Recruiting Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Condition: Liver Transplantation
Interventions: Biological: Anti-Thymocyte Globulin - Rabbit;   Biological: darTreg Infusion;   Drug: Everolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Prednisone;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Anti-Infective Prophylaxis;   Procedure: Leukapheresis;   Procedure: Blood draws;   Procedure: Liver biopsies;   Procedure: Liver transplantation
32 Recruiting School Inner-City Asthma Intervention Study (SICAS-2)
Condition: Asthma
Interventions: Other: integrated pest management;   Other: air purifier;   Other: No intervention (control)
33 Recruiting Chitinases and Transforming Growth Factor Beta (TGFB) in Human Asthma
Condition: Asthma
Intervention:
34 Recruiting Genomics of Kidney Transplantation
Condition: Kidney Transplantation
Intervention:
35 Recruiting ATG-GCSF in New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Anti-Thymocyte Globulin (ATG);   Drug: Granulocyte colony stimulating factor (GCSF);   Drug: Placebo (for ATG);   Drug: Placebo (for GCSF)
36 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
37 Recruiting The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery
Condition: Peanut Allergy
Interventions: Drug: Peanut Protein 4,000mg;   Drug: Oat Flour;   Drug: Peanut Protein 300 mg
38 Recruiting Validation of Gene Expression Markers of Renal Allograft Functional Decline
Condition: Kidney Transplant Recipients
Intervention:
39 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
40 Recruiting Pathway to Prevention Study
Condition: Diabetes Mellitus, Type 1
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years